Familial amyloidosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
==Treatment== | ==Treatment== | ||
[[Familial amyloidosis medical therapy|Medical Therapy | [[Familial amyloidosis medical therapy|Medical Therapy]] | [[Familial amyloidosis surgery|Surgery]] | [[Familial amyloidosis primary prevention|Primary Prevention]] | [[Familial amyloidosis secondary prevention|Secondary Prevention]] | [[Familial amyloidosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Familial amyloidosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 20:11, 25 November 2019
|
Familial amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Familial amyloidosis On the Web |
|
American Roentgen Ray Society Images of Familial amyloidosis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Familial amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies